CervoMed Inc.

CRVO · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 15 employees
426
SEC Filings
$2.44
Close 2026-09-16
15
Employees

Business Summary

CervoMed Inc. is a clinical-stage biotechnology company developing treatments for age-related brain disorders. Its lead drug candidate, neflamapimod, is an orally administered small-molecule p38 inhibitor targeting neuroinflammation and synaptic dysfunction. Neflamapimod is in clinical development for Dementia with Lewy Bodies (DLB), nonfluent variant primary progressive aphasia (nfvPPA), Rapid Eye Movement Sleep Behavior Disorder Associated Synucleinopathy (RAS), and ALS. There are no approved therapies for DLB in the US or EU.

Latest Stock Quote

CRVO 2026-09-16 $2.44 O:$2.45 H:$2.5192 L:$2.4 Vol:0.1M VWAP:$2.4451
origin leaf: null

Next Earnings

expected 2026-12-10

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-132025-12-310001437749-26-008259EDGAR90K words
2025-03-172024-12-310001437749-25-007829EDGAR90K words
2024-03-292023-12-310001437749-24-010064EDGAR92K words
2023-03-242022-12-310001437749-23-007795EDGAR—
2022-03-182021-12-310001437749-22-006737EDGAR—
2021-03-172020-12-310001437749-21-006236EDGAR—
2020-03-172019-12-310001437749-20-005469EDGAR—
2019-03-192018-12-310001437749-19-005256EDGAR—
2018-04-022017-12-310001437749-18-006050EDGAR—
2017-03-312016-12-310001437749-17-005713EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-072026-06-300001437749-26-026592EDGAR24K words
2025-11-072025-09-300001437749-25-033879EDGAR25K words
2025-08-082025-06-300001437749-25-025570EDGAR22K words
2025-05-122025-03-310001437749-25-015966EDGAR19K words
2024-11-122024-09-300001437749-24-034344EDGAR23K words
2024-08-092024-06-300001437749-24-025875EDGAR23K words
2024-05-142024-03-310001437749-24-016615EDGAR19K words
2023-11-132023-09-300001437749-23-031374EDGAR58K words
2023-08-082023-06-300001437749-23-022535EDGAR18K words
2023-05-152023-03-310001437749-23-014359EDGAR16K words
2022-11-142022-09-300001437749-22-027266EDGAR—
2022-08-122022-06-300001437749-22-020219EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-100001437749-26-030073EDGAR1K words
2026-08-100001437749-26-026771EDGAR3K words
2026-08-040001437749-26-025509EDGAR1K words
2026-07-140001437749-26-023538EDGAR2K words
2026-03-230001437749-26-009388EDGAR1K words
2026-03-190001437749-26-009081EDGAR2K words
2026-03-170001437749-26-008611EDGAR1K words
2026-03-040001437749-26-006911EDGAR1K words
2026-02-180001437749-26-004555EDGAR1K words
2026-01-080001437749-26-000883EDGAR1K words

426 total filings indexed. 394 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

dementia-with-lewy-bodies-(dlb) nonfluent-variant-primary-progressive-aphasia-(nfvppa) rem-sleep-behavior-disorder-associated-synucleinopathy-(ras) amyotrophic-lateral-sclerosis-(als) neurodegenerative-disease-therapeutics

Company Identity

CIK0001053691
TickerCRVO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.cervomed.com
Listed1996-06-18

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 0e03c974328aa0e75f8ace5e1fc4cbf618c22ddd8860981421293ee9821c3f92
parent: d97ce1e6383b5fe9f481516304411c9236cb9dcccec29c2f3f2ee13c66d86d1b
content hash: d8e5b776b892bd05f9f1a388cfdb5b85682184c06cf90546ec63e54ed290a036
signed: 2026-09-28T19:00:52.332Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CRVO using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CRVO, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CRVO (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.